In conclusion, the results presented demonstrate that BCI, a putative DUSP1/6 inhibitor, is cytotoxic in a range of NB cell lines and induces a short‐lived activation of the AKT and stress‐inducible MAP kinases. The gene discussed is AKT1; the disease is neuroblastoma.